Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Biotech
Biotech
Vertex doubles down on CRISPR Tx and diabetes in new $100M deal
Historically known for developing cystic fibrosis treatments, Vertex is going deeper into diabetes and its work with CRISPR Tx in a $330 million deal.
Max Bayer
Mar 27, 2023 11:41am
BrainStorm finds path to FDA for twice-dismissed ALS drug
Mar 27, 2023 11:02am
Jounce jilts Redx for Concentra's surprise merger offer
Mar 27, 2023 10:56am
Vaxxinity seeks a partner to press ahead with Alzheimer's med
Mar 27, 2023 10:53am
Codiak Biosciences files for bankruptcy
Mar 27, 2023 10:42am
Neuraly points to younger patients as Parkinson's bet fails
Mar 27, 2023 10:37am
